Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome

NIH RePORTER · NIH · R03 · $366,125 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT Down syndrome is the most prevalent genetic condition in humans and a major cause of intellectual disability. Although the severity and extent of phenotypes present in Down syndrome partially result from an extra copy of chromosome 21, details regarding the biological mechanisms and the emergence of atypical development is not understood. To address this significant gap in knowledge, we previously created a ‘Developmental Cell Atlas of Down Syndrome’ by using single-cell RNA-sequencing to profile the transcriptomes of over 700,000 cells derived from multiple tissues. This proposal represents our ongoing efforts to characterize the molecular and cellular identity of cellular phenotypes present in the developing brain in Down syndrome. In Aim 1, we will map the Down syndrome cells onto a reference framework of the developing human brain by pooling existing single-cell RNA-sequencing data. In Aim 2, we will use our established human brain functional genomics pipeline to infer cell-type-specific gene regulatory networks altered in Down syndrome. Leveraging existing data, this study will provide critical information about the emergence and regulation of early brain development in Down syndrome that can be used to elucidate the molecular mechanisms underlying early neuropathology and to benchmark model systems for disease relevant neuronal phenotypes.

Key facts

NIH application ID
10304101
Project number
1R03NS123969-01
Recipient
SEATTLE CHILDREN'S HOSPITAL
Principal Investigator
Kimberly Anne Aldinger
Activity code
R03
Funding institute
NIH
Fiscal year
2021
Award amount
$366,125
Award type
1
Project period
2021-09-01 → 2023-08-31